N-glucuronidation catalyzed by UGT1A4 and UGT2B10 in human liver microsomes: Assay optimization and substrate identification

被引:25
作者
Lu, Danyi [1 ,2 ,3 ]
Xie, Qian [1 ,3 ]
Wu, Baojian [1 ,3 ]
机构
[1] Jinan Univ, Coll Pharm, Res Ctr Biopharmaceut & Pharmacokinet, Guangzhou, Guangdong, Peoples R China
[2] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen Key Lab Mol Biol Neural Dev, Guangdong Key Lab Nanomed,Inst Biomed & Biotechno, Shenzhen, Peoples R China
[3] Jinan Univ, Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
N-glucuronidation; UGT1A4; UGT2B10; Species differences; Tertiary amines; UDP-GLUCURONOSYLTRANSFERASES; SERUM CONCENTRATION; METABOLISM; NICOTINE; SELECTIVITIES; AMITRIPTYLINE; POLYMORPHISM; LAMOTRIGINE; COTININE; KINETICS;
D O I
10.1016/j.jpba.2017.07.037
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
N-glucuronidation is an important pathway for metabolism and disposition of tertiary amines in humans. This reaction is mainly catalyzed by the enzymes UGT1A4 and UGT2B10. However, the metabolic patterns of UGT1A4- and UGT2B10-mediated N-glucuronidation are not fully clear. In this study, we first optimized in vitro reaction conditions for N-glucuronidation by using specific substrates (i.e., trifluoperazine for UGT1A4, cotinine and amitriptyline for UGT2B10). Furthermore, we found that hepatic N-glucuronidation showed significant species differences. In addition, UGT1A4 and UGT2B10 were primarily responsible for N-glucuronidation of many tertiary amines, including asenapine, loxapine, clozapine, chlorpromazine, dothiepin, doxepin, mirtazapine, mianserin, chlorcyclizine, cyclizine, promethazine, cyclobenzaprine, imatinib, retrorsine, strychnine and brucine. In conclusion, this study provides an in vitro assay system for evaluating N-glucuronidation of amines. Also, UGT1A4- and UGT2B10-mediated N-glucuronidation might play significant roles in metabolism and detoxification of tertiary amines in humans. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:692 / 703
页数:12
相关论文
共 19 条
  • [1] Human UDP-Glucuronosyltransferase (UGT) 2B10 in Drug N-Glucuronidation: Substrate Screening and Comparison with UGT1A3 and UGT1A4
    Kato, Yukiko
    Izukawa, Takeshi
    Oda, Shingo
    Fukami, Tatsuki
    Finel, Moshe
    Yokoi, Tsuyoshi
    Nakajima, Miki
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (07) : 1389 - 1397
  • [2] Effect of Aging on Glucuronidation of Valproic Acid in Human Liver Microsomes and the Role of UDP-Glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10
    Argikar, Upendra A.
    Remmel, Rory P.
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (01) : 229 - 236
  • [3] Identification and Characterization of Oxymetazoline Glucuronidation in Human Liver Microsomes: Evidence for the Involvement of UGT1A9
    Mahajan, Mukesh K.
    Uttamsingh, Vinita
    Can, Liang-Shang
    Leduc, Barbara
    Williams, David A.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (02) : 784 - 793
  • [4] Glucuronidation of macelignan by human liver microsomes and expressed UGT enzymes: identification of UGT1A1 and 2B7 as the main contributing enzymes
    Liu, Hongming
    Wu, Zhufeng
    Ma, Zhiguo
    Wu, Baojian
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2014, 35 (09) : 513 - 524
  • [5] Use of Phenotypically Poor Metabolizer Individual Donor Human Liver Microsomes To Identify Selective Substrates of UGT2B10
    Milani, Nicolo
    Qiu, NaHong
    Molitor, Birgit
    Badee, Justine
    Cruciani, Gabriele
    Fowler, Stephen
    DRUG METABOLISM AND DISPOSITION, 2020, 48 (03) : 176 - 186
  • [6] Glucuronidation of piceatannol by human liver microsomes: major role of UGT1A1, UGT1A8 and UGT1A10
    Miksits, Michaela
    Maier-Salamon, Alexandra
    Thanh Phuong Nha Vo
    Sulyok, Michael
    Schuhmacher, Rainer
    Szekeres, Thomas
    Jaeger, Walter
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 62 (01) : 47 - 54
  • [7] Effects of a Novel UGT2B Haplotype and UGT1A4*3 Allele Variants on Glucuronidation of Clozapine In vivo
    Smith, Robert Lovsletten
    Wollmann, Birgit M.
    Kausberg, Marianne
    Maeland, Sondre
    Tveito, Marit
    O'Connell, Kevin
    Molden, Espen
    Kringen, Marianne Kristiansen
    CURRENT DRUG METABOLISM, 2022, 23 (01) : 66 - 72
  • [8] Identification of specific UGT1A9-mediated glucuronidation of licoricidin in human liver microsomes
    Cho, Pil Joung
    Kim, Ju-Hyun
    Lee, Hye Suk
    Kim, Jeong Ah
    Lee, Sangkyu
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2019, 40 (02) : 94 - 98
  • [9] Nicotine N-glucuronidation relative to N-oxidation and C-oxidation and UGT2B10 genotype in five ethnic/racial groups
    Murphy, Sharon E.
    Park, Sung-Shim L.
    Thompson, Elizabeth F.
    Wilkens, Lynne R.
    Patel, Yesha
    Stram, Daniel O.
    Le Marchand, Loic
    CARCINOGENESIS, 2014, 35 (11) : 2526 - 2533
  • [10] Potential Regulation of UGT2B10 and UGT2B7 by miR-485-5p in Human Liver
    Sutliff, Aimee K.
    Shi, Jian
    Watson, Christy J. W.
    Hunt, Martina S.
    Chen, Gang
    Zhu, Hao-Jie
    Lazarus, Philip
    MOLECULAR PHARMACOLOGY, 2019, 96 (06) : 674 - 682